Literature DB >> 17584866

Chy-3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia.

Michael T Dellinger1, Robert J Hunter, Michael J Bernas, Marlys H Witte, Robert P Erickson.   

Abstract

Recent advances in molecular lymphology and lymphatic phenotyping techniques in small animals offer new opportunities to delineate mutant mouse models. Chy-3 mutant mice were originally named for their chylous ascites, but the underlying lymphatic disorder was not defined. We now re-examined these mice and applied advanced genotyping and lymphatic phenotyping techniques to pinpoint the specific lymphatic defect in this mouse model. We demonstrated that Chy-3 mice carry a large chromosomal deletion that includes Vegfc and narrowed this region by monitoring the heterozygosity of genetic markers. We found that Chy-3 mice not only exhibited chylous ascites but also lymphedema of the hind paws and, in approximately half of the males, lymphedema of the penis. Visual lymphangiography and immunofluorescence staining showed a hypoplastic dermal lymphatic network, whereas the blood vasculature appeared unaffected. This hypoplastic lymphatic network was functional, and all adult Chy-3 mice exhibited a lateral lymphatic pathway directly connecting the inguinal to the axillary lymph node. The dermal superficial to deep lymphatic connections in upper limbs and in all cervical regions were intact and functionally drained the upper body. Lymphatic tracer was not transported from the dermal to the deep truncal lymphatic system in the lower limbs, even though the deep lymphatic vessels and nodes were present and patent. These findings further delineate the lymphatic phenotype of Chy-3 mice, identify a collateral lymph drainage pathway previously undescribed in other genetic models of lymphedema, and demonstrate a predilection for lymphatic abnormalities of the lower limbs. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584866     DOI: 10.1002/dvdy.21208

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  22 in total

1.  Gastrointestinal lymphatics in health and disease.

Authors:  J S Alexander; Vijay C Ganta; P A Jordan; Marlys H Witte
Journal:  Pathophysiology       Date:  2010-09

Review 2.  Lymphangiogenesis and hemangiogenesis: potential targets for therapy.

Authors:  Marlys H Witte; Michael T Dellinger; Donald M McDonald; S David Nathanson; Francesco M Boccardo; Corradino C C Campisi; Jonathan P Sleeman; Jeffrey E Gershenwald
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

3.  Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema.

Authors:  Joseph M Rutkowski; Carl Erik Markhus; Christina C Gyenge; Kari Alitalo; Helge Wiig; Melody A Swartz
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

4.  Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia.

Authors:  Andrew M Platt; Joseph M Rutkowski; Catherine Martel; Emma L Kuan; Stoyan Ivanov; Melody A Swartz; Gwendalyn J Randolph
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

5.  Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow.

Authors:  Alanna Ruddell; Maria I Harrell; Satoshi Minoshima; Kenneth R Maravilla; Brian M Iritani; Steven W White; Savannah C Partridge
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

6.  Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice.

Authors:  Michael Dellinger; Robert Hunter; Michael Bernas; Nicholas Gale; George Yancopoulos; Robert Erickson; Marlys Witte
Journal:  Dev Biol       Date:  2008-04-27       Impact factor: 3.582

Review 7.  Genetics of lymphatic anomalies.

Authors:  Pascal Brouillard; Laurence Boon; Miikka Vikkula
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

8.  Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration.

Authors:  Hwee Ying Lim; Joseph M Rutkowski; Julie Helft; Sai T Reddy; Melody A Swartz; Gwendalyn J Randolph; Véronique Angeli
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

Review 9.  Targeting angiogenesis and lymphangiogenesis in kidney disease.

Authors:  Katsuyuki Tanabe; Jun Wada; Yasufumi Sato
Journal:  Nat Rev Nephrol       Date:  2020-03-06       Impact factor: 28.314

Review 10.  Pediatric lymphatic malformations: evolving understanding and therapeutic options.

Authors:  Ann M Defnet; Naina Bagrodia; Sonia L Hernandez; Natalie Gwilliam; Jessica J Kandel
Journal:  Pediatr Surg Int       Date:  2016-01-27       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.